Endothelial function as a determinant of vascular function and structure: A new therapeutic target

被引:129
|
作者
Gibbons, GH
机构
来源
AMERICAN JOURNAL OF CARDIOLOGY | 1997年 / 79卷 / 5A期
关键词
D O I
10.1016/S0002-9149(97)00122-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent insights into the pathogenesis of vascular disease have opened up a new frontier that has implications for future therapies, The vasculature has been redefined as a vital organ that can regulate its own tone and structure via numerous cellular mechanisms, The endothelium plays the role of gatekeeper in this process, sensing and responding to stimuli and activating various vasoactive systems that function as mediators, Locally generated vasoactive substances such as angiotensin II and nitric oxide appear to be important determinants of vessel function and structure, Vasoactive substances generated within the endothelium influence cell proliferation and cell death in a complex interplay that, when disturbed, can result in structural alteration known as vascular remodeling, Normal vascular homeostasis is maintained by a balance between vasoconstrictors such as angiotensin II and vasodilators such as nitric oxide, Endothelial dysfunction involves an imbalance between vasoactive substances such that perturbations in the regulation of tone, hemostasis, and vessel structure result in the development of cardiovascular diseases, such as hypertension, atherosclerosis, end heart failure. (C) 1997 by Excerpta Medica, Inc.
引用
收藏
页码:3 / 8
页数:6
相关论文
共 50 条
  • [1] Tetrahydrobiopterin: A Vascular Redox Target to Improve Endothelial Function
    Channon, Keith M.
    CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (06) : 705 - 708
  • [2] Endothelial function as a therapeutic target in coronary artery disease.
    Sharma N.
    Andrews T.C.
    Current Atherosclerosis Reports, 2000, 2 (4) : 303 - 307
  • [3] Inflammation as a Therapeutic Target To Improve Vascular Function in Kidney Disease
    Walther, Carl P.
    Navaneethan, Sankar D.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (03): : 723 - 725
  • [4] Endothelial function - A critical determinant in atherosclerosis?
    Landmesser, U
    Hornig, B
    Drexler, H
    CIRCULATION, 2004, 109 (21) : 27 - 33
  • [5] EPCS IS A DETERMINANT OF VASCULAR FUNCTION AND ATHEROSCLEROSIS IN AS
    Syngle, A.
    Garg, N.
    Verma, I.
    Krishan, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 421 - 421
  • [6] VASCULAR FAILURE AND VASCULAR ENDOTHELIAL FUNCTION
    Node, Koichi
    JOURNAL OF VASCULAR RESEARCH, 2009, 46 : 55 - 55
  • [7] NADPH Oxidase - a Therapeutic Target to Restore Endothelial Function in Insulin Resistance
    Sukumar, Piruthivi
    Viswambharan, Hema
    Imrie, Helen
    Gage, Matthew
    Yuldasheva, Nadira
    Wheatcroft, Stephen
    Kearney, Mark
    CIRCULATION, 2011, 124 (21)
  • [8] Genetic modification of vascular endothelial function as therapeutic strategy in heart failure
    Lam, CF
    Katusic, ZS
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 289 (02): : H518 - H519
  • [9] Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition
    Holmes, Katherine
    Roberts, Owain Ll
    Thomas, Angharad M.
    Cross, Michael J.
    CELLULAR SIGNALLING, 2007, 19 (10) : 2003 - 2012
  • [10] ENDOTHELIAL CONTROL OF VASCULAR FUNCTION
    DANIEL, TO
    IVES, HE
    NEWS IN PHYSIOLOGICAL SCIENCES, 1989, 4 : 139 - 142